News

Capacity expansion for crop protection products

CropScience to invest €30 million in Dormagen

Bayer CropScience will invest some €30 million over the next two years to expand production capacities for the active ingredient prothioconazole at the Dormagen Chempark.

Zoom image

Bayer CropScience will invest some €30 million over the next two years to expand production capacities for the active ingredient prothioconazole at the Dormagen Chempark.

In response to rising demand for fungicides, CropScience AG will invest some €30 million in the next two years to expand production capacities at the Dormagen Chempark for the active ingredient prothioconazole. Dormagen is one of the biggest production sites of Bayer CropScience worldwide.

Prothioconazole is registered in more than 40 countries for use in cereal, canola, soybeans, legumes and peanuts. This modern active ingredient, which is marketed worldwide, features significant, long-lasting efficacy against a broad spectrum of fungal diseases in plants. Prothioconazole also counteracts the development of mycotoxins, fungi that pose a danger to health and are a frequent cause of food poisoning. In 2008 fungicides based on prothioconazole accounted for global sales of €246 million, putting them among the ten most important Bayer CropScience products.